💡 We don’t necessarily need more drugs for #RA - we need to use existing ones more effectively. Here's a recent article of the @ec.europa.eu's HORIZON magazine on SQUEEZE, feat. @danielaletaha.bsky.social & @agneskocher2.bsky.social projects.research-and-innovation.ec.europa.eu/en/horizon-m...

High disease activity is high disease activity is high disease activity? - Nope! Not all patients with rheumatoid arthritis are the same – even when they have exactly the same disease activity score! Full article: pubmed.ncbi.nlm.nih.gov/41839530/ Part of #SPIDERR and @squeezeproject.bsky.social

Congratulations to our scientific coordinator @meduniwien.ac.at for 30 years of University Rheumatology in Austria! Learn more about SQUEEZE via: squeeze-project.eu

New publication on therapeutic drug monitoring of biological drugs. Certolizumab plasma concentrations were influenced by dose & dose adjustments in a predictable manner shows newly published data by REMEDY and SQUEEZE: journals.lww.com/drug-monitor...

SQUEEZE tries to understand why #RheumatoidArthritis (RA) behaves so differently from one person to another & how this knowledge can help make treatment more personalised. This paper led by LUMC shows that WHERE #RA affects the body at diagnosis really matters: www.nature.com/articles/s41...

💊 Taking medication sounds simple - but for many people with RA, it isn’t. A scoping review protocol led by @agneskocher2.bsky.social et al. in 2024 focused on #adherence to DMARDs. This work reviews decades of research to better understand what influences adherence: osf.io/gb8dk/files/...

Learn more about the SQUEEZE project by exploring one of our first publications. 📰 rmdopen.bmj.com/content/10/4...

They have a #RMDream @squeezeproject.bsky.social #WAD2025

The #SQUEEZE care model is being presented at Oslo @squeezeproject.bsky.social meeting We will finally get to know the 3 components 😍: ePROM assessment-> segmentation-> tailored adherence intervention

When @squeezeproject.bsky.social people meet during the summer 🌞🕶️

At the Dresden Symposium on Autoantibodies 2025, Daniela Sieghart presented on biomarkers for RA treatment response, highlighting EU projects @squeezeproject.bsky.social & @autopix.bsky.social. Our division drives precision medicine forward, tailoring care through innovative biomarkers.

How to run #clinicaltrials in EU consortia? SQUEEZE expert Daniela Sieghart of @meduniwien.ac.at shares insights into the work of managing clinical studies during the Austrian Research Promotion Agency Coffee Chats on "Health in Action". 🎬 Watch the full talk via www.youtube.com/watch?v=3u6U...

Where's your SQUEEZE bag spending the summer? 😉☀️

How can we possibly fill the void after the end of #EULAR2025? Maybe by watching @eular.org's Kristina Chingov explain how to involve patient research partners in EU consortia during an Austrian Research Promotion Agency #FFG -led virtual coffee talk. ☕ Watch via 👉 www.youtube.com/watch?v=oyOC...

#EULAR2025 also offered the possibilty to come together for scientific project meetings. The @squeezeproject.bsky.social Wp8 team spent very productive 2 hours on steering the trajectories for our #adherence and #implementation ideas

Check out my interview, masterfully led by Valentina Pucino after the plenary session of #EULAR2025 👇 www.youtube.com/watch?v=d6hi...

Full house and engaging discussions at Tjardo Marseveens (LUMC) talks today at #EULAR2025! Follow the SQUEEZE project on our LinkedIn channel or website to learn more about our latest results: LinkedIn: www.linkedin.com/company/sque... Web: squeeze-project.eu

We're back for Day 3 of #EULAR2025 with insights on the latest science done by the SQUEEZE consortium. Join us at booth #O3 in the glass walkway, near the Science Café. Our SciComm team is ready to introduce you to the work done in our project!🤗 @nicoleschmidtvie.bsky.social @caro-neum.bsky.social

Evaluation of the Torque Teno Virus as a potential immunologic marker in #RheumatoidArthritis presented by Daniel Mrak today. Interested in the potential of TTV as an "immunometer"? Follow @ttvguidetx.bsky.social on TTV-guided dosing of immunosuppressive drugs in kidney transplant recipients. #TTV

If you are at #EULAR2025, come and visit us at our stand in the Glass Walkway in the NPO Exhibition. You can win an anti-stress hippo and learn more about our HIPPOCRATES project including our HPOS study. 👉 hippocrates-imi.eu 👉 www.hpos.study

We had the great pleasure of welcoming a special guest at our booth yesterday. We consider ourselves very fortunate to have @danielaletaha.bsky.social & his glorious team at @meduniwien.ac.at leading our project. EU projects are highly complex & it's crucial to cruise with the right captain & crew!

At 3.15 pm today, SQUEEZE expert Daniela Di Giuseppe will present a poster during the poster tour comparing biological, targeted & conventional options of second DMARDs after #MTX in European RA cohorts. We are trying to understand which second #DMARD choice is the best for which group of patients.

Want to learn more about the contextual analysis done to develop the SQUEEZE Care Model? Come join us at booth #O3 in the NPO area / glass walkway and study the poster presented yesterday by the @inmusc.bsky.social team around @loreto-carmona.bsky.social. #EULAR2025

Full house and engaging discussions during @nilssteinz.bsky.social ‘s talk “Add-on vs. Replacement csDMARD Strategies Post-Methotrexate: A European analysis on csDMARD Treatment Choices" - exciting research funded by @squeezeproject.bsky.social & sister project SPIDERR led by Rachel Knevel at LUMC.

Day 2 of #EULAR2025 kicking off with a first highlight. Here's SQUEEZE expert @nilssteinz.bsky.social (LUMC) getting ready at the SQUEEZE booth for his talk "Add-on vs. Replacement csDMARD Strategies Post-Methotrexate: A European analysis on csDMARD Treatment Choices". 📍 Starting NOW in room A.2!

@meduniwien.ac.at is everywhere! 🤙🏼🥰

Day 1 at #EULAR2025 is coming to an end and we were happy and proud about the strong poster presence we had today by SQUEEZE experts from @inmusc.bsky.social and @meduniwien.ac.at i.e. on challenges in implementing evidence-based health interventions in the European Union.

Join by at the poster presentation of Claudia Hana on trajectories of #MTX use in patients with RA this afternoon at m348 @squeezeproject.bsky.social #EULAR2025

Meet #RheumaBuddy Andreas Dam, our SQUEEZE superhero on a quest to improve the lives of #RA patients. At SQUEEZE we are working on squeezing the most out of existing DMARDs through three clinical trials led by Queen Mary Universit London, @meduniwien.ac.at and Diakonhjemmet Hospital Oslo. #EULAR2025

Our booth is ready! And we are too! The #SQUEEZE booth team @nicoleschmidtvie.bsky.social and @caro-neum.bsky.social is geared up for #EULAR2025. Join us for chats about our three clinical trials, the SQUEEZE Care Model, the HealthBuddy App and #patientengagement.📍 Booth #O3 👥 #Rheumatology #RA

Meet the SQUEEZE team at #EULAR2025!! Here's our final pre-Congress alert for the final day, Day 3, June 13 where Tjardo Maarseveen (LUMC) will end the SQUEEZE inputs with a bang by giving two talks. 🥳 Want to learn more about SQUEEZE? 📍Visit us at our booth no O3 in the NPO area close to Hall 8.1!!

🖼️ Posters, posters, posters! Join us on Day 2 of #EULAR2025 in the poster area 📍and learn more about the work of @agneskocher2.bsky.social and further SQUEEZE experts on #adherence, the Torque Teno Virus #TTV 🦠, user-friendly web tools, and the choice and effectiveness of second #DMARDs.

Meet the SQUEEZE team at #EULAR2025!! Each day, experts of our team will present first results of our work. June 11 kicks off with three poster views by representatives of @inmusc.bsky.social & @meduniwien.ac.at Want to learn more about SQUEEZE? 📍Visit us at booth O3 in the NPO area. #RA

🎙️ Join us on June 12, @ 11 am CEST, when PhD student Christina Wettengl from Institute of Nursing Science / @unibas.ch will present the Contextual Analysis done to develop the SQUEEZE Care Model for DMARDs adherence & Implementation Strategies at #EULAR2025, in room C1. #DigitalHealth #RA #Adherence

Watch @danielaletaha.bsky.social highlight the innovative research behind SQUEEZE and emphasize how we are actively integrating patients into our efforts, ensuring their voices shape the future of rheumatology. Also, there's insights into our plans for #EULAR2025. www.youtube.com/watch?v=7lVV...

🎙️ Mark the first of many SQUEEZE talks at #EULAR2025: "Add-on vs. Replacement csDMARDs post-MTX. A European analysis on csDMARD Treatment Choices." Presented by Nils Steinz from Leiden University Medical Center (LUMC) on June 12, at 10:50 am at room A2. #RA #DMARD #PrecisionMedicine

We’re thrilled to promote SQUEEZE's presence at #EULAR2025 🇪🇸! Via 4 talks & 8 posters our team will present first results of our research on biomarker-driven #RA care, patient adherence, and DMARD optimisation. Follow us for updates from the congress floor! #Rheumatology #PrecisionMedicine

🟣 Today, on International Day of Action for Women’s Health, we reaffirm: women’s health is central to rheumatology - from research to care. Let’s keep pushing forward. may28.org #WomensHealthMatters #Rheumatology #AutoimmuneDiseases #HealthEquity

@squeezeproject.bsky.social is at #EULAR2025!! Come join us at our booth, learn about our first results and support growing the #RA community here on BlueSky!! Can't wait to meet everyone onsite in Barcelona for insights into the latest scientific findings in the field of #RMDs. #Rheumatology

What is the EULAR Congress? Why is it relevant for #RA patients? Hear from EULAR president @danielaletaha.bsky.social what the EULAR Congress is about and why it is worth joining it! Daniel also shares interesting insights into his EULAR presidency. Watch via: www.youtube.com/watch?v=rvf5...

An incredibly inspiring day in Basel, advancing the development of the Squeeze Care Model @squeezeproject.bsky.social